New Asthma Medication

New asthma mild antibodies include Xolair with anti-IgE antibody. Anti-IL-5 such as Fasenra, Singulair, Nucala and Dupixent, which is a T, is also available. These drugs treat superficial inflammatory pathways. Deeper pathways with new drugs are coming on soon.

PT SLP and other drugs also affect the basement membrane. It is believed that the cells lining are normal. There might be chronic damage. A patient needs to have a chronic cough and exacerbation to receive this medication. Severe asthmatics enumerating PT SLP should be able to deal with the results of neutrophilic asthma which is currently not treated by medically affected anti-TNF therapy and anti-IL 6.

---

If you need to book an appointment for your allergies or asthma, you can book your appointment online, or call 212-247-7447.